Total Payments
$97,024
2024 Payments
$3,880
Companies
57
Transactions
1,424
Medicare Patients
1,990
Medicare Billing
$308,685
Payment Breakdown by Category
Food & Beverage$48,065 (49.5%)
Other$40,130 (41.4%)
Travel$4,580 (4.7%)
Consulting$4,200 (4.3%)
Education$49.55 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $48,065 | 1,349 | 49.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,130 | 28 | 41.4% |
| Travel and Lodging | $4,580 | 38 | 4.7% |
| Consulting Fee | $4,200 | 3 | 4.3% |
| Education | $49.55 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $49,861 | 206 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $6,451 | 184 | $0 (2024) |
| Gilead Sciences, Inc. | $6,302 | 105 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,745 | 106 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,465 | 104 | $0 (2024) |
| Allergan Inc. | $2,845 | 29 | $0 (2019) |
| Novo Nordisk Inc | $2,576 | 60 | $0 (2024) |
| Amgen Inc. | $2,244 | 48 | $0 (2024) |
| Merck Sharp & Dohme LLC | $2,081 | 82 | $0 (2024) |
| ABBVIE INC. | $1,898 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,880 | 94 | AstraZeneca Pharmaceuticals LP ($940.51) |
| 2023 | $5,046 | 134 | AstraZeneca Pharmaceuticals LP ($789.34) |
| 2022 | $4,891 | 151 | Novo Nordisk Inc ($814.00) |
| 2021 | $7,193 | 175 | AstraZeneca Pharmaceuticals LP ($871.21) |
| 2020 | $8,475 | 132 | Janssen Pharmaceuticals, Inc ($5,624) |
| 2019 | $25,654 | 246 | Janssen Pharmaceuticals, Inc ($18,443) |
| 2018 | $20,992 | 244 | Janssen Pharmaceuticals, Inc ($10,307) |
| 2017 | $20,894 | 248 | Janssen Pharmaceuticals, Inc ($13,961) |
All Payment Transactions
1,424 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: VACCINE | ||||||
| 12/06/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: GI | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $112.95 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.93 | General |
| 11/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $116.67 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: VACCINE | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Bone Health | ||||||
| 10/25/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.72 | General |
| Category: GI | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $85.53 | General |
| Category: VACCINE | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $111.93 | General |
| Category: VACCINE | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.49 | General |
| 10/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: VACCINE | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.85 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 437 | 821 | $120,420 | $66,704 |
| 2022 | 9 | 463 | 1,115 | $167,510 | $81,971 |
| 2021 | 6 | 513 | 1,305 | $183,500 | $87,534 |
| 2020 | 8 | 577 | 1,272 | $184,550 | $72,476 |
Total Patients
1,990
Total Services
4,513
Medicare Billing
$308,685
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 329 | $49,350 | $24,666 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 137 | $27,400 | $15,926 | 58.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $15,450 | $9,234 | 59.8% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 27 | 27 | $10,800 | $6,515 | 60.3% |
| 90746 | Hepatitis b vaccine, adult dosage (3 dose schedule) | Office | 2023 | 22 | 41 | $4,920 | $2,828 | 57.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 59 | $2,950 | $2,191 | 74.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 48 | 48 | $2,400 | $1,783 | 74.3% |
| G0010 | Administration of hepatitis b vaccine | Office | 2023 | 21 | 40 | $2,000 | $1,486 | 74.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 56 | 59 | $2,950 | $1,204 | 40.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 22 | $2,200 | $872.30 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 624 | $93,600 | $40,557 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 173 | $34,600 | $19,859 | 57.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 83 | 83 | $20,750 | $13,021 | 62.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 38 | 74 | $7,400 | $3,074 | 41.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 62 | 62 | $3,100 | $2,277 | 73.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 62 | 62 | $3,100 | $1,244 | 40.1% |
| 90746 | Hepatitis b vaccine, adult dosage (3 dose schedule) | Office | 2022 | 11 | 13 | $1,560 | $896.61 | 57.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 11 | $2,750 | $563.33 | 20.5% |
| G0010 | Administration of hepatitis b vaccine | Office | 2022 | 11 | 13 | $650.00 | $477.49 | 73.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 139 | 756 | $113,400 | $49,745 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 206 | $41,200 | $24,922 | 60.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 80 | 131 | $13,100 | $4,821 | 36.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 26 | $6,500 | $4,217 | 64.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 90 | 93 | $4,650 | $1,980 | 42.6% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 90 | 93 | $4,650 | $1,849 | 39.8% |
About Dr. Edward Ko, MD
Dr. Edward Ko, MD is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841364841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Ko, MD has received a total of $97,024 in payments from pharmaceutical and medical device companies, with $3,880 received in 2024. These payments were reported across 1,424 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($48,065).
As a Medicare-enrolled provider, Ko has provided services to 1,990 Medicare beneficiaries, totaling 4,513 services with total Medicare billing of $308,685. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location San Francisco, CA
- Active Since 11/20/2006
- Last Updated 10/13/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841364841
Products in Payments
- INVOKANA (Drug) $46,912
- Vemlidy (Drug) $4,459
- XARELTO (Drug) $3,072
- FARXIGA (Drug) $2,740
- VIBERZI (Drug) $2,599
- JARDIANCE (Drug) $2,529
- TRELEGY ELLIPTA (Drug) $1,905
- ELIQUIS (Drug) $1,116
- Kerendia (Drug) $1,106
- Ozempic (Drug) $944.70
- BEVESPI AEROSPHERE (Drug) $906.89
- NUZYRA (Drug) $800.00
- Linzess (Drug) $783.78
- BREZTRI (Drug) $745.38
- NUEDEXTA (Drug) $730.35
- Prolia (Biological) $710.99
- EVENITY (Biological) $661.98
- Rybelsus (Drug) $634.48
- STIOLTO RESPIMAT (Drug) $572.72
- TRULICITY (Drug) $565.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Francisco
Dr. Fred Cohen, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
John Teerlink, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Kenneth Binmoeller, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Hope Rugo, Md, MD
Internal Medicine — Payments: $881,117
Internal Medicine $881,117
Dr. Steven Harris, M.d, M.D
Internal Medicine — Payments: $806,637
Internal Medicine $806,637
Dr. Kenneth Colley, Md, MD
Internal Medicine — Payments: $732,736
Internal Medicine $732,736